David Shaw’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-61,500
Closed -$692K – 4391
2024
Q4
$692K Hold
61,500
– – ﹤0.01% 3424
2024
Q3
$1.74M Buy
+61,500
New +$1.59M ﹤0.01% 2810
2022
Q2
– Sell
-20,000
Closed -$646K – 5446
2022
Q1
$646K Hold
20,000
– – ﹤0.01% 4214
2021
Q4
$553K Buy
+20,000
New +$574K ﹤0.01% 4345

Other funds holding EVH

David Shaw's EVH Position: Q3 2026 in Review

David Shaw reduced its Evolent Health (EVH) stake by 34% in Q3 2026, selling an estimated $7.67M and leaving 3,377,687 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1663.

David Shaw first reported a position in EVH in Q3 2015 and has held it in 30 quarters since. The position peaked at $27.7M in Q2 2026. 193 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • David Shaw held 3,377,687 shares of Evolent Health worth $11.8M as of Q3 2026.
  • David Shaw sold 1,729,874 Evolent Health shares in Q3 2026, an estimated $7.67M.
  • Evolent Health made up 0.01% of David Shaw's portfolio in Q3 2026, its #1663 holding.
  • David Shaw first reported a position in Evolent Health in Q3 2015 and has held it in 30 quarters since.
  • David Shaw's Evolent Health position peaked at $27.7M in Q2 2026.
  • 193 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.